Table 1.
Patient characteristics
| Variables | n (%)/mean ± SD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 66.91 ± 12.93 | Male patients | 18 (39.13) | Female patients | 28 (60.87) | Adrenal lesions | 49 | Patients with adrenal adenomas | 31 (67.39) | Number of adrenal adenomas | 32 (65.31) | Breast cancer | 6 (19.35) | Colon and rectal cancer | 3 (9.67) | Ovarian cancer | 3 (9.67) | Lymphoma | 3 (9.67) | Hepatocellular carcinoma | 3 (9.67) | Oropharyngeal carcinoma | 2 (6.45) | Melanoma | 2 (6.45) | Uveal melanoma | 1 (3.23) | Laryngeal carcinoma | 1 (3.23) | Pancreatic cancer | 1 (3.23) | Esophageal cancer | 1 (3.23) | Gastrointestinal stromal tumor | 1 (3.23) | Neuroendocrine tumor (Ileum) | 1 (3.23) | Cancer of unknown primary (CUP) | 1 (3.23) | Renal cell carcinoma | 1 (3.23) | Cholangiocarcinoma |
1 (3.23) |
Patients with adrenal metastases | 15 (32.61) | Number of adrenal metastases | 17 (34.69) | Melanoma | 3 (17.65) | Renal cell carcinoma | 3 (17.65) | Ovarian cancer | 3 (17.65) | Hepatocellular carcinoma | 3 (17.65) | Breast cancer | 2 (11.76) | Lung cancer | 2 (11.76) | Uveal melanoma | 1 (5.88) |
SD, standard deviation.